Biomedical research translated for UK readers
Dr Dooa Arif is a biomedical researcher and science writer with a PhD in Nanoscience and Engineering and a research background in electrochemical biosensors, nanomaterials and diagnostic sensing technologies. Her work helps translate complex biomedical research into accessible, evidence-led health content.
Her doctoral work at the National University of Sciences and Technology focused on metal-organic-framework based electrochemical sensors for glucose detection. She also holds a master’s degree in Biomedical Science, where her work included antibacterial nanocomposite coatings for biomedical applications, and a bachelor’s degree in Biotechnology.
Dr Arif’s research experience spans non-enzymatic glucose and dopamine sensing, smart hypoxia detection, functional nanocomposites, MOFs, point-of-care diagnostics, wearable and flexible bioelectronics, and laboratory methods including electrochemical analysis, microscopy, XRD and UV-Vis characterisation. That background gives her a practical understanding of how measurement technologies are developed, validated and communicated.
For mescreen™ UK, Dr Arif’s remit is science writing: explaining mitochondrial-health, biomarker and diagnostics topics in language that informed consumers can use. Hemal Patel, PhD, remains the named reviewer/editor for clinical interpretation and preventative-health claims, so authorship and review are clearly separated.
